Overcoming drug-resistant lung cancer by paclitaxel-loaded hyaluronic acid-coated liposomes targeted to mitochondria

References

• Biswas S, Dodwadkar NS, Sawant RR, et al. Surface modification of liposomes with rhodamine-123-conjugated polymer results in enhanced mitochondrial targeting. J Drug Target. 2011;19:552–561.
   PubMed Web of Science ®Google Scholar
• Jiang L, Li L, He X, et al. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response. Biomaterials. 2015;52:126–139.
   PubMed Web of Science ®Google Scholar
• Deshpande PP, Biswas S, Torchilin VP. Current trends in the use of liposomes for tumor targeting. Nanomedicine (Lond). 2013;8:1509–1528.
   PubMed Web of Science ®Google Scholar
• Dai L, Liu J, Luo Z, et al. Tumor therapy: targeted drug delivery systems. J Mater Chem B. 2016;4:6758–6772.
   PubMed Web of Science ®Google Scholar
• Wang ZJ, Guo WL, Kuang X, et al. Nanopreparations for mitochondria targeting drug delivery system: current strategies and future prospective. Asian J Pharm Sci. 2017;12:498–508.
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65:36–48.
   PubMed Web of Science ®Google Scholar
• Koudelka S, Turanek J. Liposomal paclitaxel formulations. J Control Release. 2012;163:322–334.
   PubMed Web of Science ®Google Scholar
• Bernabeu E, Cagel M, Lagomarsino E, et al. Paclitaxel: what has been done and the challenges remain ahead. Int J Pharm. 2017;526:474–495.
   PubMed Web of Science ®Google Scholar
• Cho HJ, Yoon HY, Koo H, et al. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic(R) for tumor-targeted delivery of docetaxel. Biomaterials. 2011;32:7181–7190.
   PubMed Web of Science ®Google Scholar
• Dufaÿ Wojcicki A, Hillaireau H, Nascimento TL, et al. Hyaluronic acid-bearing lipoplexes: physico-chemical characterization and in vitro targeting of the CD44 receptor. J Control Release. 2012;162:545–552.
   PubMed Web of Science ®Google Scholar
• Ebbesen MF, Olesen MT, Gjelstrup MC, et al. Tunable CD44-specific cellular retargeting with hyaluronic acid nanoshells. Pharm Res. 2015;32:1462–1474.
   PubMed Web of Science ®Google Scholar
• Qhattal HS, Liu X. Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes. Mol Pharm. 2011;8:1233–1246.
   PubMed Web of Science ®Google Scholar
• Gasperini AA, Puentes-Martinez XE, Balbino TA, et al. Association between cationic liposomes and low molecular weight hyaluronic acid. Langmuir. 2015;31:3308–3317.
   PubMed Web of Science ®Google Scholar
• Mattheolabakis G, Milane L, Singh A, et al. Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine. J Drug Target. 2015;23:605–618.
   PubMed Web of Science ®Google Scholar
• Sangtani A, Nag OK, Field LD, et al. Multifunctional nanoparticle composites: progress in the use of soft and hard nanoparticles for drug delivery and imaging. Wires Nanomed Nanobiotechnol. 2017;9:e1466.
   Web of Science ®Google Scholar
• Yang T, Cui FD, Choi MK, et al. Liposome formulation of paclitaxel with enhanced solubility and stability. Drug Deliv. 2007;14:301–308.
   PubMed Web of Science ®Google Scholar
• Roger E, Lagarce F, Benoit JP. The gastrointestinal stability of lipid nanocapsules. Int J Pharm. 2009;379:260–265.
   PubMed Web of Science ®Google Scholar
• Sun J, Jiang L, Lin Y, et al. Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides. Int J Nanomedicine. 2017;12:1517–1537.
   PubMed Web of Science ®Google Scholar
• Zhou L, Luo W. Vascular endothelial growth factor-targeted paclitaxel-loaded liposome microbubbles and inhibition of human epidermoid-2 cell proliferation. Head Neck. 2017;39:656–661.
   PubMed Web of Science ®Google Scholar
• Assanhou AG, Li W, Zhang L, et al. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment. Biomaterials. 2015;73:284–295.
   PubMed Web of Science ®Google Scholar
• Wang XX, Li YB, Yao HJ, et al. The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells. Biomaterials. 2011;32:5673–5687.
   PubMed Web of Science ®Google Scholar
• Zhao P, Wang H, Yu M, et al. Paclitaxel-loaded, folic-acid-targeted and TAT-peptide-conjugated polymeric liposomes: in vitro and in vivo evaluation. Pharm Res. 2010;27:1914–1926.
   PubMed Web of Science ®Google Scholar
• Shi Q, Zhang L, Liu M, et al. Reversion of multidrug resistance by a pH-responsive cyclodextrin-derived nanomedicine in drug resistant cancer cells. Biomaterials. 2015;67:169–182.
   PubMed Web of Science ®Google Scholar
• Bu H, He X, Zhang Z, et al. A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer. Int J Pharm. 2014;471:206–213.
   PubMed Web of Science ®Google Scholar
• Zhang JA, Anyarambhatla G, Ma L, et al. Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur J Pharm Biopharm. 2005;59:177–187.
   PubMed Web of Science ®Google Scholar
• Men Y, Wang XX, Li RJ, et al. The efficacy of mitochondrial targeting antiresistant epirubicin liposomes in treating resistant leukemia in animals. Int J Nanomedicine. 2011;6:3125–3137.
   PubMed Web of Science ®Google Scholar
• Yu Y, Wang ZH, Zhang L, et al. Mitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inhibiting invasive metastases of melanoma. Biomaterials. 2012;33:1808–1820.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Liu J, Zhu W, et al. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells. Acta Biomater. 2015;23:147–156.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang M, Jin H, et al. Prodrug-like, pegylated protein toxin trichosanthin for reversal of chemoresistance. Mol Pharm. 2017;14:1429–1438.
   PubMedGoogle Scholar
• Tang Y, Liang J, Wu A, et al. Co-delivery of trichosanthin and albendazole by nano-self-assembly for overcoming tumor multidrug-resistance and metastasis. ACS Appl Mater Interfaces. 2017;9:26648–26664.
   PubMed Web of Science ®Google Scholar
• Yao HJ, Sun L, Liu Y, et al. Monodistearoylphosphatidylethanolamine-hyaluronic acid functionalization of single-walled carbon nanotubes for targeting intracellular drug delivery to overcome multidrug resistance of cancer cells. Carbon. 2016;96:362–376.
   Web of Science ®Google Scholar
• Tian G, Zheng X, Zhang X, et al. TPGS-stabilized NaYbF4:Er upconversion nanoparticles for dual-modal fluorescent/CT imaging and anticancer drug delivery to overcome multi-drug resistance. Biomaterials. 2015;40:107–116.
   PubMed Web of Science ®Google Scholar
• Surace C, Arpicco S, Dufaÿ-Wojcicki A, et al. Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells. Mol Pharm. 2009;6:1062–1073.
   PubMed Web of Science ®Google Scholar
• Boddapati SV, D’Souza GGM, Erdogan S, et al. Organelle-targeted nanocarriers: specific delivery of liposomal ceramide to mitochondria enhances its cytotoxicity in vitro and in vivo. Nano Lett. 2008;8:2559–2563.
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhao WY, Ma X, et al. The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer. Biomaterials. 2013;34:3626–3638.
   PubMed Web of Science ®Google Scholar
• Wang F, Sun W, Li L, et al. Charge-reversible multifunctional HPMA copolymers for mitochondrial targeting. ACS Appl Mater Interfaces. 2017;9:27563–27574.
   PubMed Web of Science ®Google Scholar
• Weissig V, Lizano C, Torchilin VP. Selective DNA release from DQAsome/DNA complexes at mitochondria-like membranes. Drug Deliv. 2000;7:1–5.
   PubMed Web of Science ®Google Scholar